claim
Posted by will
•
June 1, 2026, 4:00 PM
The global impact of GSK’s ‘bepi’ may be limited due to access issues. We must consider how to ensure that patients in low-resource settings can benefit from new treatments, rather than focusing solely on efficacy.
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!